J 2018

Adipokines in neurovascular diseases

OPATRILOVA, Radka, Martin CAPRNDA, Peter KUBATKA, Vanda VALENTOVA, Sona URAMOVA et. al.

Basic information

Original name

Adipokines in neurovascular diseases

Authors

OPATRILOVA, Radka (203 Czech Republic), Martin CAPRNDA (703 Slovakia), Peter KUBATKA (703 Slovakia), Vanda VALENTOVA (703 Slovakia), Sona URAMOVA (703 Slovakia), Vladimir NOSAL (703 Slovakia), Ludovit GASPAR (703 Slovakia), Lukas ZACHAR (703 Slovakia), Ioana MOZOS (642 Romania), Daniel PETROVIC (705 Slovenia), Jozef DRAGASEK (703 Slovakia), Slavomira FILIPOVA (703 Slovakia), Dietrich BUSSELBERG (634 Qatar), Anthony ZULLI (36 Australia), Luis RODRIGO (724 Spain), Peter KRUŽLIAK (703 Slovakia, guarantor, belonging to the institution) and Vladimir KRASNIK (703 Slovakia)

Edition

BIOMEDICINE & PHARMACOTHERAPY, PARIS, ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2018, 0753-3322

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

France

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 3.743

RIV identification code

RIV/00216224:14110/18:00102964

Organization unit

Faculty of Medicine

UT WoS

000426104000053

Keywords in English

Adipokines; Leptin; Adiponectin; Resistin; Apelin; Visfatin; Atherosclerosis; Ischemic stroke; Metabolic changes; Inflammation

Tags

International impact, Reviewed
Změněno: 9/2/2019 20:01, Soňa Böhmová

Abstract

V originále

Adipose tissue is now described as an endocrine organ secreting a number of adipokines contributing to the development of inflammation and metabolic imbalance, but also endothelial dysfunction, vascular remodeling, atherosclerosis, and ischemic stroke. Leptin, adiponectin, and resistin are the most studied adipokines which play important roles in the regulation of cardiovascular homeostasis. Leptin and adiponectin mediate both proatherogenic and antiatherogenic responses. Leptin and adiponectin have been linked to the development of coronary heart disease and may be involved in the underlying biological mechanism of ischemic stroke. Resistin, a pro-inflammatory cytokine, is predictive of atherosclerosis and poor clinical outcomes in patients with coronary artery disease and ischemic stroke. The changes in serum levels of novel adipokines apelin, visfatin are also associated with acute ischemic stroke. These adipokines have been proposed as potential prognostic biomarkers of cardiovascular mortality/morbidity and therapeutic targets in patients with cardiometabolic diseases. In this article, we summarize the biologic role of the adipokines and discuss the link between dysfunctional adipose tissue and metabolic/inflammation imbalance, consequently endothelial damage, progression of atherosclerotic disease, and the occurrence of ischemic stroke.